Search research articles
Contact Us
Filters
Showing results (81-90 of 208) with videos related to
Page
of 21
Sort By:
Gynecologic Oncology
|
February 1, 1995
Acute myelomonocytic leukemia with abnormal eosinophils presenting as an ovarian mass: a report of two cases and a review of the literature
L C Drinkard, S Waggoner, R N Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1987
A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia
R A Larson, K M Daly, K E Choi, et al.
Journal of Vascular Surgery
|
December 7, 2000
Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery
R A Larson, M Naji, J V Lombardi, et al.
Blood
|
November 15, 1992
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia
W J Gradishar, M M Le Beau, R O'Laughlin, et al.
Photochemistry and Photobiology
|
December 1, 1989
Sanguinarine, a phototoxic H2O2-producing alkaloid
R W Tuveson, R A Larson, K A Marley, et al.
Surgery, Gynecology & Obstetrics
|
February 1, 1970
Analysis of 860 patients with carcinoma of the transverse and descending colon
R L Speck, W H Thomas, R A Larson, et al.
Leukemia
|
March 31, 1998
Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive
J Anastasi, T Musvee, D Roulston, et al.
Cancer
|
June 1, 1982
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings
R A Larson, D L Sweet, H M Golomb, et al.
Environmental Health Perspectives
|
November 1, 1986
Hypochlorous acid-activated carbon: an oxidizing agent capable of producing hydroxylated polychlorinated biphenyls
E A Voudrias, R A Larson, V L Snoeyink, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies
R A Larson, R B Geller, L Janisch, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 208) with videos related to
Sort By:
Page
of 21
Gynecologic Oncology
|
February 1, 1995
Acute myelomonocytic leukemia with abnormal eosinophils presenting as an ovarian mass: a report of two cases and a review of the literature
L C Drinkard, S Waggoner, R N Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1987
A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia
R A Larson, K M Daly, K E Choi, et al.
Journal of Vascular Surgery
|
December 7, 2000
Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery
R A Larson, M Naji, J V Lombardi, et al.
Blood
|
November 15, 1992
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia
W J Gradishar, M M Le Beau, R O'Laughlin, et al.
Photochemistry and Photobiology
|
December 1, 1989
Sanguinarine, a phototoxic H2O2-producing alkaloid
R W Tuveson, R A Larson, K A Marley, et al.
Surgery, Gynecology & Obstetrics
|
February 1, 1970
Analysis of 860 patients with carcinoma of the transverse and descending colon
R L Speck, W H Thomas, R A Larson, et al.
Leukemia
|
March 31, 1998
Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive
J Anastasi, T Musvee, D Roulston, et al.
Cancer
|
June 1, 1982
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings
R A Larson, D L Sweet, H M Golomb, et al.
Environmental Health Perspectives
|
November 1, 1986
Hypochlorous acid-activated carbon: an oxidizing agent capable of producing hydroxylated polychlorinated biphenyls
E A Voudrias, R A Larson, V L Snoeyink, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies
R A Larson, R B Geller, L Janisch, et al.
Page
of 21